A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...
“Insulin injections remain a daily burden for many patients,” said Shingo Ito, an associate professor at Kumamoto University ...
Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...
For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug ...
(1,2) "Awiqli (R) is an important new option that meets a real need as the first FDA-approved, once-weekly basal insulin for adult patients with type 2 diabetes. It's helping to reframe what basal ...
Researchers in Japan have reported a significant step in the long‑standing scientific effort to develop an insulin medication ...
March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control ...
In a breakthrough development, researchers have developed a peptide-based oral insulin delivery system that could help ...
“Insulin injections remain a daily burden for many patients,” said Associate Professor Shingo Ito. “Our peptide-based ...
Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day, to help ...
The primary factor behind diabetes is that your body may not make enough insulin (type 1 diabetes) or it fails to respond to the insulin your pancreas releases, which is known as insulin resistance ...
Please provide your email address to receive an email when new articles are posted on . A group of experts updated the FITTER insulin injection recommendations for the first time since 2016. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results